rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Dec' 16 Sep' 16 Jun' 16 Mar' 16 Dec' 15
Sales 508.60 477.74 412.99 401.65 420.03
Operating profit 175.50 168.98 142.99 129.24 149.22
Interest 0.59 0.62 0.88 0.93 1.31
Gross profit 225.99 175.04 150.59 169.92 152.11
EPS (Rs) 19.33 13.67 11.30 15.34 11.68
Quarterly  results in details
Dec' 16 Sep' 16 Jun' 16 Mar' 16 Dec' 15
Other income 51.08 6.68 8.48 41.61 4.20
Stock adjustment 12.79 3.53 -3.04 -18.05 -17.16
Raw material 96.93 102.80 94.44 101.26 117.34
Power and fuel - - - - -
Employee expenses 69.28 66.63 64.78 63.53 58.47
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 154.10 135.80 113.82 125.67 112.16
Provisions made - - - - -
Depreciation 14.73 13.45 12.43 11.55 11.12
Taxation 40.28 40.64 38.25 22.66 37.65
Net profit / loss 170.98 120.95 99.91 135.71 103.34
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 17.69 17.69 17.69 17.69 17.69
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 34.51 35.37 34.62 32.18 35.53
GPM (%) 40.38 36.13 35.73 38.33 35.86
NPM (%) 30.55 24.97 23.71 30.62 24.36
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close